Rivernorth Capital Management’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-58,548
| Closed | -$1.76K | – | 707 |
|
|
2023
Q1 | $1.76K | Hold |
58,548
| – | – | ﹤0.01% | 599 |
|
|
2022
Q4 | $2.93K | Buy |
58,548
+25,216
| +76% | +$1.26K | ﹤0.01% | 634 |
|
|
2022
Q3 | $1K | Hold |
33,332
| – | – | ﹤0.01% | 848 |
|
|
2022
Q2 | $2K | Hold |
33,332
| – | – | ﹤0.01% | 792 |
|
|
2022
Q1 | $6K | Hold |
33,332
| – | – | ﹤0.01% | 791 |
|
|
2021
Q4 | $19K | Hold |
33,332
| – | – | ﹤0.01% | 663 |
|
|
2021
Q3 | $27K | Hold |
33,332
| – | – | ﹤0.01% | 505 |
|
|
2021
Q2 | $35K | Hold |
33,332
| – | – | ﹤0.01% | 457 |
|
|
2021
Q1 | $42K | Buy |
+33,332
| New | +$42K | ﹤0.01% | 416 |
|